Back to Search
Start Over
Market Exclusivity for Biologics.
- Source :
-
New England Journal of Medicine . 2/18/2010, Vol. 362 Issue 7, p661-662. 2p. - Publication Year :
- 2010
-
Abstract
- A response by Alfred B. Engelberg and Aaron S. Kesselheim to a letter to the editor about their article "Balancing Innovation, Access, and Profits: Market Exclusivity for Biologics" in the November 12, 2009 issue is presented.
- Subjects :
- *LETTERS to the editor
*BIOLOGICALS
Subjects
Details
- Language :
- English
- ISSN :
- 00284793
- Volume :
- 362
- Issue :
- 7
- Database :
- Academic Search Index
- Journal :
- New England Journal of Medicine
- Publication Type :
- Academic Journal
- Accession number :
- 48166918
- Full Text :
- https://doi.org/10.1056/NEJMc0912463